Research ArticleClinical Studies

Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment

TORU AOYAMA, AYA KATO, ITARU HASHIMOTO, YUKIO MAEZAWA, KENTARO HARA, SHINNOSUKE KAWAHARA, KEISUKE KAZAMA, KEISUKE KOMORI, SUZUE YOSHIZAWA, AYAKO TAMAGAWA, MINORI TATEISHI, TOMOYUKI MINAMI, HARUHIKO CHO, JUNYA MORITA, KAZUKI OTANI, SHO SAWAZAKI, MASAKATAU NUMATA, MIE TANABE, TAKASHI OSHIMA, AYA SAITO, NORIO YUKAWA and YASUSHI RINO
Anticancer Research January 2024, 44 (1) 249-255; DOI: https://doi.org/10.21873/anticanres.16808

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment
TORU AOYAMA, AYA KATO, ITARU HASHIMOTO, YUKIO MAEZAWA, KENTARO HARA, SHINNOSUKE KAWAHARA, KEISUKE KAZAMA, KEISUKE KOMORI, SUZUE YOSHIZAWA, AYAKO TAMAGAWA, MINORI TATEISHI, TOMOYUKI MINAMI, HARUHIKO CHO, JUNYA MORITA, KAZUKI OTANI, SHO SAWAZAKI, MASAKATAU NUMATA, MIE TANABE, TAKASHI OSHIMA, AYA SAITO, NORIO YUKAWA, YASUSHI RINO
Anticancer Research Jan 2024, 44 (1) 249-255; DOI: 10.21873/anticanres.16808
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords